Telo Genomics Corp.
TDSGF
$0.03
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.53% | 8.19% | -6.30% | -27.30% | -43.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.08% | 0.31% | -3.90% | -14.57% | -22.97% |
| Operating Income | -5.08% | -0.31% | 3.90% | 14.57% | 22.97% |
| Income Before Tax | -8.04% | -1.32% | 2.94% | 15.01% | 23.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -8.04% | -1.32% | 2.94% | 15.01% | 23.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.04% | -1.32% | 2.94% | 15.01% | 23.97% |
| EBIT | -5.08% | -0.31% | 3.90% | 14.57% | 22.97% |
| EBITDA | -5.12% | -1.21% | 3.01% | 14.06% | 22.84% |
| EPS Basic | 20.43% | 21.97% | 21.07% | 28.26% | 32.28% |
| Normalized Basic EPS | 21.62% | 22.89% | 21.59% | 28.22% | 31.80% |
| EPS Diluted | 0.75% | 6.36% | 7.02% | 15.90% | 23.86% |
| Normalized Diluted EPS | 21.62% | 22.89% | 21.59% | 28.22% | 31.80% |
| Average Basic Shares Outstanding | 36.21% | 30.60% | 23.04% | 17.07% | 11.30% |
| Average Diluted Shares Outstanding | 36.21% | 30.60% | 23.04% | 17.07% | 11.30% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |